← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Genesegues, Inc.
Chaska, MN
$3,141,281
Total funding
8
Grants
Funding over time
peak $1.3M · FY2006–14$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,141,281 · 8
By mechanism
R43$1,756,208 · 6
N01$1,200,000 · 1
N43$185,073 · 1
Investigators at Genesegues, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000$1,000,000
N01 · FY2014 · CA
Nanocapsule-mediated topical delivery of VLP-generating Dengue DNA vaccine$300,000
R43 · FY2013 · AI
Nanocapsule-mediated topical delivery of VLP-generating Dengue DNA vaccine$300,000
R43 · FY2014 · AI
Antisense gene therapy with tumor-targeted nanocapsules$245,059
R43 · FY2003 · CA
Nonviral vehicles targeting liver cell-subtypes for nuclear delivery via rafts$203,015
R43 · FY2010 · DK
Nonviral vehicles targeting liver cell-subtypes for nuclear delivery via rafts$203,015
R43 · FY2009 · DK
TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000$200,000
N43 · FY2013 · CA
402 - RFP: N43-CM-87007-68 Topic 251: Development of Anticancer Agents Reques$185,073
N43 · FY2008 · CA
Topical delivery of nanoencapsulated plasmid DNA to posterior ocular targets$158,983
R43 · FY2012 · EY
S50 nanocapsules for transcutaneous DNA vaccination$146,661
R43 · FY2004 · AI
Tumor-targeted delivery of siRNA via sub-50 nanometer capsules$99,746
R43 · FY2007 · CA
Tumor-targeted delivery of siRNA via sub-50 nanometer capsules$99,729
R43 · FY2006 · CA